| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tight Junctions | 21 | 2026 | 158 | 4.770 |
Why?
|
| Claudins | 13 | 2026 | 50 | 4.030 |
Why?
|
| Colitis, Ulcerative | 17 | 2026 | 824 | 2.090 |
Why?
|
| Claudin-2 | 3 | 2026 | 18 | 1.920 |
Why?
|
| Colon | 17 | 2026 | 561 | 1.800 |
Why?
|
| Calcium | 17 | 2024 | 1196 | 1.790 |
Why?
|
| Intestinal Mucosa | 23 | 2026 | 834 | 1.700 |
Why?
|
| Colonic Pouches | 5 | 2025 | 99 | 1.660 |
Why?
|
| Inflammatory Bowel Diseases | 10 | 2025 | 677 | 1.340 |
Why?
|
| Sodium-Calcium Exchanger | 11 | 2013 | 22 | 1.330 |
Why?
|
| Epithelial Cells | 11 | 2018 | 709 | 1.240 |
Why?
|
| Zonula Occludens-1 Protein | 8 | 2020 | 70 | 1.230 |
Why?
|
| Proctocolectomy, Restorative | 5 | 2025 | 117 | 1.170 |
Why?
|
| Atrial Fibrillation | 5 | 2024 | 460 | 1.100 |
Why?
|
| Occludin | 8 | 2020 | 66 | 1.010 |
Why?
|
| Crohn Disease | 8 | 2025 | 844 | 0.970 |
Why?
|
| Electron Microscope Tomography | 1 | 2026 | 25 | 0.950 |
Why?
|
| Pancreatic Ducts | 1 | 2026 | 37 | 0.950 |
Why?
|
| Pancreatitis, Chronic | 1 | 2026 | 89 | 0.890 |
Why?
|
| Cryoelectron Microscopy | 1 | 2026 | 141 | 0.880 |
Why?
|
| Molecular Dynamics Simulation | 3 | 2026 | 325 | 0.850 |
Why?
|
| Membrane Proteins | 12 | 2014 | 1285 | 0.830 |
Why?
|
| Transcriptome | 3 | 2025 | 820 | 0.800 |
Why?
|
| T-Box Domain Proteins | 3 | 2019 | 139 | 0.750 |
Why?
|
| Animals | 58 | 2026 | 28910 | 0.750 |
Why?
|
| Organoids | 4 | 2026 | 91 | 0.680 |
Why?
|
| Mice | 41 | 2026 | 12707 | 0.680 |
Why?
|
| Colitis | 8 | 2018 | 264 | 0.650 |
Why?
|
| Ion Channels | 3 | 2024 | 259 | 0.630 |
Why?
|
| Colonic Neoplasms | 9 | 2016 | 582 | 0.630 |
Why?
|
| Atrioventricular Node | 1 | 2020 | 37 | 0.620 |
Why?
|
| Epithelium | 5 | 2024 | 316 | 0.620 |
Why?
|
| Heart Rate | 2 | 2020 | 534 | 0.610 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2018 | 707 | 0.600 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2 | 2019 | 30 | 0.590 |
Why?
|
| Mutant Proteins | 2 | 2019 | 98 | 0.590 |
Why?
|
| Transcription Factors | 4 | 2024 | 1717 | 0.560 |
Why?
|
| Myocytes, Cardiac | 6 | 2020 | 328 | 0.560 |
Why?
|
| Mice, Inbred C57BL | 20 | 2026 | 3605 | 0.520 |
Why?
|
| Humans | 77 | 2026 | 97894 | 0.510 |
Why?
|
| Sodium | 7 | 2013 | 330 | 0.510 |
Why?
|
| Pancreatic Neoplasms | 5 | 2026 | 769 | 0.510 |
Why?
|
| Dogs | 5 | 2026 | 639 | 0.500 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2020 | 238 | 0.500 |
Why?
|
| Biological Transport | 2 | 2015 | 401 | 0.470 |
Why?
|
| Myosin-Light-Chain Kinase | 3 | 2010 | 41 | 0.450 |
Why?
|
| Muscle Cells | 3 | 2002 | 16 | 0.420 |
Why?
|
| Ion Transport | 5 | 2026 | 86 | 0.410 |
Why?
|
| Forkhead Transcription Factors | 6 | 2021 | 183 | 0.410 |
Why?
|
| Disease Models, Animal | 12 | 2026 | 2572 | 0.400 |
Why?
|
| Cell Proliferation | 8 | 2026 | 1790 | 0.390 |
Why?
|
| Colectomy | 2 | 2025 | 201 | 0.390 |
Why?
|
| Gastric Mucosa | 1 | 2013 | 72 | 0.380 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2026 | 156 | 0.370 |
Why?
|
| Inflammation | 8 | 2023 | 1121 | 0.350 |
Why?
|
| Heart Failure | 6 | 2024 | 1491 | 0.340 |
Why?
|
| Adenoma | 2 | 2016 | 260 | 0.340 |
Why?
|
| Permeability | 7 | 2021 | 145 | 0.340 |
Why?
|
| Patch-Clamp Techniques | 6 | 2017 | 381 | 0.340 |
Why?
|
| Myocardium | 4 | 2002 | 578 | 0.330 |
Why?
|
| Male | 27 | 2026 | 46996 | 0.330 |
Why?
|
| Mice, Knockout | 10 | 2026 | 2208 | 0.320 |
Why?
|
| Artificial Intelligence | 2 | 2026 | 473 | 0.320 |
Why?
|
| Antibodies, Monoclonal, Humanized | 3 | 2025 | 1098 | 0.320 |
Why?
|
| Adenocarcinoma | 5 | 2019 | 1211 | 0.320 |
Why?
|
| Cholangitis, Sclerosing | 2 | 2023 | 59 | 0.310 |
Why?
|
| Sarcoplasmic Reticulum | 6 | 2019 | 24 | 0.310 |
Why?
|
| Gastrointestinal Agents | 2 | 2025 | 197 | 0.310 |
Why?
|
| Interleukin-13 | 1 | 2010 | 42 | 0.310 |
Why?
|
| Up-Regulation | 4 | 2026 | 743 | 0.290 |
Why?
|
| Signal Transduction | 10 | 2023 | 3623 | 0.280 |
Why?
|
| Epigenesis, Genetic | 2 | 2025 | 588 | 0.270 |
Why?
|
| Tight Junction Proteins | 2 | 2020 | 14 | 0.270 |
Why?
|
| Caco-2 Cells | 6 | 2018 | 128 | 0.270 |
Why?
|
| Toxoplasmosis | 2 | 2020 | 68 | 0.270 |
Why?
|
| Toxoplasma | 2 | 2020 | 114 | 0.260 |
Why?
|
| Interferon-gamma | 2 | 2026 | 479 | 0.260 |
Why?
|
| Interleukin-10 | 4 | 2016 | 167 | 0.260 |
Why?
|
| Female | 26 | 2026 | 51464 | 0.250 |
Why?
|
| Colorectal Neoplasms | 4 | 2023 | 1103 | 0.250 |
Why?
|
| Case-Control Studies | 4 | 2025 | 1995 | 0.250 |
Why?
|
| Middle Aged | 18 | 2025 | 29353 | 0.250 |
Why?
|
| Gene Regulatory Networks | 3 | 2024 | 337 | 0.250 |
Why?
|
| Antineoplastic Agents | 4 | 2023 | 2373 | 0.250 |
Why?
|
| Ceruletide | 1 | 2026 | 9 | 0.240 |
Why?
|
| Severity of Illness Index | 6 | 2026 | 2008 | 0.230 |
Why?
|
| Static Electricity | 1 | 2026 | 101 | 0.230 |
Why?
|
| Mucoproteins | 1 | 2025 | 21 | 0.230 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2026 | 68 | 0.230 |
Why?
|
| Cell Membrane | 4 | 2008 | 673 | 0.230 |
Why?
|
| Action Potentials | 5 | 2003 | 611 | 0.230 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 2 | 2020 | 278 | 0.230 |
Why?
|
| Young Adult | 9 | 2025 | 7504 | 0.230 |
Why?
|
| Intestines | 4 | 2020 | 441 | 0.230 |
Why?
|
| Pancreatitis | 1 | 2026 | 105 | 0.230 |
Why?
|
| Myocardial Contraction | 7 | 2016 | 193 | 0.230 |
Why?
|
| Glutamine | 1 | 2026 | 98 | 0.220 |
Why?
|
| Diterpenes | 2 | 2023 | 24 | 0.220 |
Why?
|
| beta Catenin | 3 | 2014 | 267 | 0.220 |
Why?
|
| Dysbiosis | 2 | 2016 | 101 | 0.220 |
Why?
|
| Models, Biological | 7 | 2017 | 1806 | 0.220 |
Why?
|
| Extracellular Matrix | 1 | 2026 | 258 | 0.210 |
Why?
|
| Phenanthrenes | 1 | 2023 | 4 | 0.200 |
Why?
|
| Indans | 1 | 2024 | 40 | 0.200 |
Why?
|
| Cell Line, Tumor | 10 | 2026 | 2892 | 0.200 |
Why?
|
| Atrial Remodeling | 1 | 2024 | 23 | 0.200 |
Why?
|
| Cell Line | 6 | 2015 | 2483 | 0.200 |
Why?
|
| Cell Membrane Permeability | 2 | 2018 | 121 | 0.200 |
Why?
|
| Kinetics | 4 | 2017 | 1477 | 0.200 |
Why?
|
| Adult | 15 | 2025 | 29453 | 0.190 |
Why?
|
| Prodrugs | 1 | 2023 | 53 | 0.190 |
Why?
|
| Cysteine Endopeptidases | 2 | 2014 | 89 | 0.190 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 219 | 0.190 |
Why?
|
| Fibroblasts | 1 | 2026 | 767 | 0.190 |
Why?
|
| Disease Progression | 2 | 2026 | 1609 | 0.190 |
Why?
|
| Endocytosis | 3 | 2013 | 187 | 0.190 |
Why?
|
| Ventricular Function | 1 | 2002 | 41 | 0.190 |
Why?
|
| Homeostasis | 4 | 2020 | 474 | 0.180 |
Why?
|
| Calcium Signaling | 3 | 2019 | 142 | 0.180 |
Why?
|
| Gene Expression Profiling | 2 | 2025 | 1565 | 0.180 |
Why?
|
| Aged | 14 | 2025 | 21702 | 0.180 |
Why?
|
| Wnt Signaling Pathway | 2 | 2021 | 105 | 0.180 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2022 | 46 | 0.180 |
Why?
|
| Claudin-4 | 2 | 2020 | 8 | 0.180 |
Why?
|
| Kynurenine | 2 | 2020 | 25 | 0.180 |
Why?
|
| Dementia | 1 | 2024 | 226 | 0.180 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2021 | 4 | 0.170 |
Why?
|
| Tryptophan | 2 | 2020 | 108 | 0.170 |
Why?
|
| Epidermal Growth Factor | 2 | 2012 | 116 | 0.170 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2022 | 85 | 0.170 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2014 | 403 | 0.170 |
Why?
|
| Helicobacter Infections | 1 | 2021 | 36 | 0.170 |
Why?
|
| Helicobacter pylori | 1 | 2021 | 36 | 0.170 |
Why?
|
| Cells, Cultured | 3 | 2021 | 2855 | 0.160 |
Why?
|
| Gastritis | 1 | 2021 | 38 | 0.160 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2001 | 57 | 0.160 |
Why?
|
| Cellular Reprogramming | 1 | 2021 | 51 | 0.160 |
Why?
|
| Plasma Cells | 1 | 2021 | 89 | 0.160 |
Why?
|
| Stomach | 1 | 2021 | 110 | 0.160 |
Why?
|
| Diet | 1 | 2023 | 468 | 0.160 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2020 | 86 | 0.160 |
Why?
|
| Mice, Transgenic | 6 | 2021 | 1605 | 0.160 |
Why?
|
| Lifting | 1 | 2020 | 12 | 0.160 |
Why?
|
| Retrospective Studies | 6 | 2025 | 10947 | 0.160 |
Why?
|
| Parasites | 1 | 2020 | 12 | 0.160 |
Why?
|
| Citrobacter rodentium | 2 | 2011 | 14 | 0.160 |
Why?
|
| Lymph Nodes | 1 | 2024 | 560 | 0.160 |
Why?
|
| Microfluidics | 1 | 2020 | 60 | 0.160 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2020 | 18 | 0.150 |
Why?
|
| Endoscopic Mucosal Resection | 1 | 2020 | 31 | 0.150 |
Why?
|
| Drug Discovery | 2 | 2022 | 120 | 0.150 |
Why?
|
| Lymphocyte Activation | 2 | 2021 | 822 | 0.150 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2021 | 358 | 0.150 |
Why?
|
| Myosin Heavy Chains | 1 | 2020 | 92 | 0.150 |
Why?
|
| Connexin 43 | 1 | 2020 | 95 | 0.150 |
Why?
|
| Biomarkers, Tumor | 4 | 2016 | 1764 | 0.150 |
Why?
|
| Carcinogenesis | 2 | 2019 | 242 | 0.150 |
Why?
|
| Polyethylene Glycols | 2 | 2012 | 382 | 0.150 |
Why?
|
| Respiratory Mucosa | 1 | 2020 | 91 | 0.150 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2020 | 115 | 0.150 |
Why?
|
| Serotonin | 1 | 2020 | 211 | 0.150 |
Why?
|
| Cations, Divalent | 1 | 2019 | 34 | 0.150 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2011 | 285 | 0.140 |
Why?
|
| Phosphoproteins | 5 | 2012 | 264 | 0.140 |
Why?
|
| Clinical Trials as Topic | 1 | 2024 | 1125 | 0.140 |
Why?
|
| Actins | 3 | 2015 | 480 | 0.140 |
Why?
|
| Connexins | 1 | 2020 | 208 | 0.140 |
Why?
|
| KRIT1 Protein | 1 | 2018 | 62 | 0.140 |
Why?
|
| Janus Kinases | 1 | 2018 | 25 | 0.140 |
Why?
|
| Myosin Type II | 1 | 2018 | 50 | 0.140 |
Why?
|
| Genetic Loci | 1 | 2019 | 263 | 0.140 |
Why?
|
| Apoptosis | 3 | 2023 | 1752 | 0.140 |
Why?
|
| Computer Simulation | 3 | 2017 | 1145 | 0.140 |
Why?
|
| Allosteric Regulation | 3 | 2003 | 78 | 0.140 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2018 | 44 | 0.130 |
Why?
|
| Asymptomatic Diseases | 1 | 2018 | 46 | 0.130 |
Why?
|
| Mixed Tumor, Malignant | 1 | 2017 | 4 | 0.130 |
Why?
|
| Calcineurin Inhibitors | 1 | 2018 | 55 | 0.130 |
Why?
|
| Janus Kinase Inhibitors | 1 | 2018 | 35 | 0.130 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2017 | 16 | 0.130 |
Why?
|
| RNA, Untranslated | 1 | 2017 | 70 | 0.130 |
Why?
|
| Madin Darby Canine Kidney Cells | 1 | 2017 | 23 | 0.130 |
Why?
|
| rho-Associated Kinases | 1 | 2018 | 162 | 0.130 |
Why?
|
| Pyrazoles | 1 | 2018 | 160 | 0.130 |
Why?
|
| Wound Healing | 2 | 2018 | 384 | 0.130 |
Why?
|
| Biopsy | 4 | 2026 | 1224 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2015 | 254 | 0.120 |
Why?
|
| RNA, Small Interfering | 4 | 2012 | 564 | 0.120 |
Why?
|
| Protein Binding | 4 | 2013 | 1555 | 0.120 |
Why?
|
| Risk Factors | 2 | 2025 | 6224 | 0.120 |
Why?
|
| Pouchitis | 1 | 2017 | 58 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 3 | 2013 | 731 | 0.120 |
Why?
|
| Rabbits | 4 | 2013 | 581 | 0.120 |
Why?
|
| Lymphocytes | 1 | 2018 | 461 | 0.120 |
Why?
|
| Dextran Sulfate | 2 | 2015 | 71 | 0.120 |
Why?
|
| Gastrointestinal Motility | 1 | 2016 | 26 | 0.120 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 762 | 0.120 |
Why?
|
| Interleukin-15 | 1 | 2016 | 78 | 0.120 |
Why?
|
| Butyrates | 1 | 2016 | 62 | 0.120 |
Why?
|
| Quinolones | 1 | 2016 | 57 | 0.120 |
Why?
|
| Mutation | 2 | 2026 | 4396 | 0.120 |
Why?
|
| Leukemia | 1 | 2018 | 308 | 0.120 |
Why?
|
| Foundations | 1 | 2015 | 15 | 0.120 |
Why?
|
| Sequence Deletion | 2 | 2013 | 207 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 2 | 2013 | 256 | 0.110 |
Why?
|
| Physiology | 1 | 2015 | 17 | 0.110 |
Why?
|
| Peptide Hormones | 1 | 2015 | 30 | 0.110 |
Why?
|
| Spectrum Analysis | 1 | 2015 | 119 | 0.110 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2016 | 95 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2017 | 298 | 0.110 |
Why?
|
| Neuroendocrine Tumors | 1 | 2017 | 157 | 0.110 |
Why?
|
| In Vitro Techniques | 4 | 2021 | 945 | 0.110 |
Why?
|
| Claudin-1 | 3 | 2011 | 17 | 0.110 |
Why?
|
| DNA-Binding Proteins | 2 | 2018 | 1254 | 0.110 |
Why?
|
| Ion Channel Gating | 1 | 2017 | 318 | 0.110 |
Why?
|
| Aspirin | 1 | 2015 | 168 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 682 | 0.100 |
Why?
|
| Immunity, Innate | 1 | 2018 | 481 | 0.100 |
Why?
|
| Stomach Neoplasms | 1 | 2017 | 319 | 0.100 |
Why?
|
| Biomarkers | 4 | 2025 | 2016 | 0.100 |
Why?
|
| Forkhead Box Protein O3 | 5 | 2013 | 23 | 0.100 |
Why?
|
| Caveolin 1 | 2 | 2013 | 24 | 0.100 |
Why?
|
| Cell Separation | 3 | 2003 | 200 | 0.100 |
Why?
|
| Leiomyosarcoma | 1 | 2014 | 48 | 0.100 |
Why?
|
| Cytokines | 4 | 2021 | 889 | 0.100 |
Why?
|
| Down-Regulation | 5 | 2013 | 529 | 0.100 |
Why?
|
| Interferon Type I | 1 | 2015 | 170 | 0.100 |
Why?
|
| Phosphorylation | 5 | 2018 | 1145 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 164 | 0.100 |
Why?
|
| Bifidobacterium | 1 | 2013 | 21 | 0.100 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 1133 | 0.100 |
Why?
|
| Lung | 1 | 2020 | 1406 | 0.090 |
Why?
|
| Capsaicin | 1 | 2012 | 43 | 0.090 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 1 | 2012 | 22 | 0.090 |
Why?
|
| TRPV Cation Channels | 1 | 2012 | 16 | 0.090 |
Why?
|
| Rectal Neoplasms | 1 | 2014 | 138 | 0.090 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 566 | 0.090 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2012 | 16 | 0.090 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2014 | 168 | 0.090 |
Why?
|
| Immunohistochemistry | 3 | 2025 | 1815 | 0.090 |
Why?
|
| Chlorides | 1 | 2012 | 102 | 0.090 |
Why?
|
| Ileum | 2 | 2025 | 172 | 0.090 |
Why?
|
| Adolescent | 6 | 2021 | 10078 | 0.090 |
Why?
|
| Microbiota | 2 | 2016 | 467 | 0.090 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2012 | 59 | 0.090 |
Why?
|
| Neoplasm Proteins | 2 | 2013 | 551 | 0.090 |
Why?
|
| Klebsiella Infections | 1 | 2012 | 35 | 0.090 |
Why?
|
| Opportunistic Infections | 1 | 2012 | 57 | 0.090 |
Why?
|
| Bacteria | 1 | 2016 | 545 | 0.090 |
Why?
|
| Klebsiella pneumoniae | 1 | 2012 | 37 | 0.090 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2013 | 86 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 750 | 0.090 |
Why?
|
| Lipopolysaccharides | 2 | 2015 | 313 | 0.090 |
Why?
|
| Interleukin-8 | 2 | 2009 | 90 | 0.090 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 221 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 1394 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2015 | 667 | 0.090 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2011 | 25 | 0.090 |
Why?
|
| Genistein | 1 | 2011 | 16 | 0.090 |
Why?
|
| Molecular Structure | 1 | 2012 | 305 | 0.090 |
Why?
|
| Bacterial Adhesion | 1 | 2011 | 84 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 2558 | 0.080 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2012 | 119 | 0.080 |
Why?
|
| ErbB Receptors | 2 | 2012 | 516 | 0.080 |
Why?
|
| Heart Ventricles | 4 | 2003 | 664 | 0.080 |
Why?
|
| Electric Conductivity | 3 | 2012 | 142 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 505 | 0.080 |
Why?
|
| Heart Atria | 2 | 2024 | 255 | 0.080 |
Why?
|
| Remission Induction | 2 | 2025 | 754 | 0.080 |
Why?
|
| Enterocytes | 2 | 2025 | 29 | 0.080 |
Why?
|
| Electrophysiology | 3 | 2011 | 384 | 0.080 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 7386 | 0.080 |
Why?
|
| Cytosol | 3 | 2010 | 193 | 0.080 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2012 | 291 | 0.080 |
Why?
|
| Tumor Microenvironment | 2 | 2026 | 618 | 0.080 |
Why?
|
| Mouth Neoplasms | 1 | 2012 | 222 | 0.080 |
Why?
|
| Tissue Culture Techniques | 1 | 2010 | 81 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 321 | 0.080 |
Why?
|
| Microscopy, Electron | 2 | 2022 | 435 | 0.080 |
Why?
|
| Protein Transport | 4 | 2013 | 448 | 0.070 |
Why?
|
| Cell Movement | 2 | 2012 | 815 | 0.070 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2009 | 48 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2025 | 1778 | 0.070 |
Why?
|
| Algorithms | 1 | 2017 | 2001 | 0.070 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2016 | 660 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2010 | 679 | 0.070 |
Why?
|
| C-Reactive Protein | 2 | 2020 | 209 | 0.070 |
Why?
|
| Plasmodium falciparum | 2 | 2020 | 57 | 0.070 |
Why?
|
| Prospective Studies | 4 | 2018 | 4798 | 0.070 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 2 | 2021 | 21 | 0.070 |
Why?
|
| T Cell Transcription Factor 1 | 2 | 2021 | 23 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 993 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 3 | 2013 | 35 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 2 | 2021 | 81 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2026 | 2783 | 0.070 |
Why?
|
| Stem Cells | 1 | 2010 | 396 | 0.070 |
Why?
|
| Cytoskeleton | 1 | 2009 | 200 | 0.070 |
Why?
|
| Matrix Metalloproteinases, Membrane-Associated | 1 | 2007 | 4 | 0.070 |
Why?
|
| Germ-Free Life | 2 | 2018 | 88 | 0.060 |
Why?
|
| Membrane Potentials | 3 | 2002 | 406 | 0.060 |
Why?
|
| Shab Potassium Channels | 1 | 2006 | 20 | 0.060 |
Why?
|
| Calcium-Transporting ATPases | 3 | 2003 | 27 | 0.060 |
Why?
|
| Genome-Wide Association Study | 3 | 2021 | 1850 | 0.060 |
Why?
|
| Arachidonic Acid | 1 | 2006 | 63 | 0.060 |
Why?
|
| Base Sequence | 1 | 2010 | 2222 | 0.060 |
Why?
|
| NF-kappa B | 2 | 2023 | 423 | 0.060 |
Why?
|
| HT29 Cells | 3 | 2011 | 50 | 0.060 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2026 | 44 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 1009 | 0.060 |
Why?
|
| Rats | 3 | 2023 | 4071 | 0.060 |
Why?
|
| Proof of Concept Study | 1 | 2025 | 63 | 0.060 |
Why?
|
| Endoscopy | 2 | 2020 | 385 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2011 | 370 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2025 | 184 | 0.050 |
Why?
|
| Observer Variation | 1 | 2026 | 579 | 0.050 |
Why?
|
| Nickel | 2 | 2002 | 14 | 0.050 |
Why?
|
| Phenotype | 2 | 2022 | 2638 | 0.050 |
Why?
|
| Logistic Models | 2 | 2018 | 1273 | 0.050 |
Why?
|
| Claudin-3 | 1 | 2024 | 3 | 0.050 |
Why?
|
| Feces | 2 | 2016 | 387 | 0.050 |
Why?
|
| Phenylmercury Compounds | 1 | 2023 | 2 | 0.050 |
Why?
|
| GATA4 Transcription Factor | 1 | 2024 | 21 | 0.050 |
Why?
|
| Oxadiazoles | 1 | 2024 | 40 | 0.050 |
Why?
|
| Epoxy Compounds | 1 | 2023 | 10 | 0.050 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2023 | 26 | 0.050 |
Why?
|
| Chemoprevention | 2 | 2015 | 93 | 0.050 |
Why?
|
| Ferrets | 2 | 2001 | 50 | 0.050 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 2 | 2014 | 18 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2010 | 2063 | 0.050 |
Why?
|
| Pancreatitis-Associated Proteins | 2 | 2014 | 18 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2024 | 181 | 0.050 |
Why?
|
| Islets of Langerhans | 1 | 2006 | 568 | 0.050 |
Why?
|
| Ions | 1 | 2003 | 75 | 0.050 |
Why?
|
| Freeze Fracturing | 1 | 2022 | 11 | 0.050 |
Why?
|
| Arginine | 1 | 2023 | 143 | 0.050 |
Why?
|
| Models, Animal | 2 | 2015 | 279 | 0.050 |
Why?
|
| Colonoscopy | 2 | 2018 | 306 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2019 | 462 | 0.050 |
Why?
|
| Intracellular Fluid | 1 | 2002 | 32 | 0.050 |
Why?
|
| Amino Acids | 1 | 2023 | 247 | 0.050 |
Why?
|
| Ligands | 1 | 2023 | 487 | 0.050 |
Why?
|
| Machine Learning | 1 | 2026 | 406 | 0.050 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2022 | 99 | 0.040 |
Why?
|
| Indoles | 1 | 2023 | 334 | 0.040 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2002 | 89 | 0.040 |
Why?
|
| Receptors, Notch | 1 | 2022 | 139 | 0.040 |
Why?
|
| Gastroscopy | 1 | 2021 | 25 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2008 | 3202 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2012 | 780 | 0.040 |
Why?
|
| Interferon Regulatory Factors | 1 | 2021 | 76 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2014 | 461 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2001 | 195 | 0.040 |
Why?
|
| Research Design | 1 | 2024 | 650 | 0.040 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2020 | 15 | 0.040 |
Why?
|
| Injections | 1 | 2020 | 131 | 0.040 |
Why?
|
| Automation | 1 | 2020 | 118 | 0.040 |
Why?
|
| Endothelium | 1 | 2020 | 63 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 197 | 0.040 |
Why?
|
| Cell Cycle | 2 | 2012 | 518 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 373 | 0.040 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2020 | 90 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2022 | 642 | 0.040 |
Why?
|
| Binding Sites | 2 | 2014 | 1159 | 0.040 |
Why?
|
| Heart | 2 | 2017 | 527 | 0.040 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2019 | 42 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 1110 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2013 | 977 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2025 | 9682 | 0.040 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2019 | 63 | 0.040 |
Why?
|
| Tumor Necrosis Factors | 1 | 2018 | 14 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2022 | 569 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2018 | 43 | 0.030 |
Why?
|
| Lactobacillus | 1 | 2018 | 26 | 0.030 |
Why?
|
| Thapsigargin | 1 | 1998 | 56 | 0.030 |
Why?
|
| Isoproterenol | 1 | 1998 | 58 | 0.030 |
Why?
|
| Penetrance | 1 | 2018 | 51 | 0.030 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2018 | 38 | 0.030 |
Why?
|
| Acinar Cells | 1 | 2017 | 8 | 0.030 |
Why?
|
| Dioxygenases | 1 | 2018 | 87 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 185 | 0.030 |
Why?
|
| Biological Therapy | 1 | 2018 | 46 | 0.030 |
Why?
|
| Nitriles | 1 | 2018 | 171 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 103 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2019 | 548 | 0.030 |
Why?
|
| Genomics | 1 | 2024 | 898 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 2017 | 122 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 308 | 0.030 |
Why?
|
| Endoscopy, Digestive System | 1 | 2017 | 73 | 0.030 |
Why?
|
| Cardiotonic Agents | 1 | 1998 | 92 | 0.030 |
Why?
|
| Cyclosporine | 1 | 2018 | 241 | 0.030 |
Why?
|
| Periodicity | 1 | 2017 | 115 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2018 | 282 | 0.030 |
Why?
|
| Tacrolimus | 1 | 2018 | 376 | 0.030 |
Why?
|
| Atrial Function | 1 | 2016 | 16 | 0.030 |
Why?
|
| Actin Cytoskeleton | 1 | 2018 | 201 | 0.030 |
Why?
|
| Parasite Egg Count | 1 | 2016 | 7 | 0.030 |
Why?
|
| Oocysts | 1 | 2016 | 8 | 0.030 |
Why?
|
| Cytochromes b | 1 | 2016 | 13 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 2018 | 183 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 836 | 0.030 |
Why?
|
| Anemia | 1 | 2017 | 135 | 0.030 |
Why?
|
| Cats | 1 | 2016 | 281 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2016 | 72 | 0.030 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2016 | 88 | 0.030 |
Why?
|
| Piroxicam | 1 | 2015 | 11 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2016 | 233 | 0.030 |
Why?
|
| Dinoprostone | 1 | 2015 | 80 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2018 | 411 | 0.030 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 220 | 0.030 |
Why?
|
| Protective Agents | 1 | 2015 | 34 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2016 | 225 | 0.030 |
Why?
|
| Anniversaries and Special Events | 1 | 2015 | 16 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2015 | 174 | 0.030 |
Why?
|
| Autophagy-Related Proteins | 1 | 2015 | 23 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 1536 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2017 | 720 | 0.030 |
Why?
|
| Rectum | 1 | 2015 | 150 | 0.030 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2014 | 24 | 0.030 |
Why?
|
| Glucuronosyltransferase | 1 | 2015 | 178 | 0.030 |
Why?
|
| Lectins, C-Type | 1 | 2014 | 74 | 0.030 |
Why?
|
| Genes, APC | 1 | 2014 | 25 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 1944 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2014 | 80 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2021 | 4000 | 0.020 |
Why?
|
| Perilipin-2 | 1 | 2013 | 2 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2014 | 353 | 0.020 |
Why?
|
| Chicago | 1 | 2018 | 1513 | 0.020 |
Why?
|
| Th17 Cells | 1 | 2014 | 97 | 0.020 |
Why?
|
| Solute Carrier Family 12, Member 2 | 1 | 2012 | 16 | 0.020 |
Why?
|
| Chromatin | 1 | 2016 | 454 | 0.020 |
Why?
|
| Colforsin | 1 | 2012 | 68 | 0.020 |
Why?
|
| Biotinylation | 1 | 2012 | 43 | 0.020 |
Why?
|
| Acrylamides | 1 | 2012 | 37 | 0.020 |
Why?
|
| 4-Nitroquinoline-1-oxide | 1 | 2012 | 15 | 0.020 |
Why?
|
| Mucin-2 | 1 | 2012 | 12 | 0.020 |
Why?
|
| Receptors, Polymeric Immunoglobulin | 1 | 2012 | 5 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2012 | 80 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2014 | 365 | 0.020 |
Why?
|
| Time Factors | 2 | 2012 | 5555 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2012 | 161 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2012 | 86 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 76 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 2012 | 71 | 0.020 |
Why?
|
| Sirtuins | 1 | 2013 | 79 | 0.020 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2012 | 112 | 0.020 |
Why?
|
| Immunity, Mucosal | 1 | 2012 | 71 | 0.020 |
Why?
|
| Incidence | 1 | 2016 | 1776 | 0.020 |
Why?
|
| Integrin beta1 | 1 | 2011 | 36 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2013 | 525 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2011 | 38 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2015 | 1781 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2015 | 1527 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 310 | 0.020 |
Why?
|
| Metagenome | 1 | 2012 | 123 | 0.020 |
Why?
|
| Dopamine | 1 | 2012 | 280 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2011 | 163 | 0.020 |
Why?
|
| Genotype | 1 | 2015 | 1888 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2013 | 256 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 889 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2011 | 86 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2012 | 674 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2012 | 479 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2010 | 128 | 0.020 |
Why?
|
| I-kappa B Kinase | 1 | 2009 | 42 | 0.020 |
Why?
|
| Child | 1 | 2021 | 7680 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2009 | 178 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 1946 | 0.020 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2008 | 12 | 0.020 |
Why?
|
| Diffusion | 1 | 2008 | 95 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2008 | 106 | 0.020 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2007 | 9 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2007 | 18 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 4023 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2008 | 122 | 0.020 |
Why?
|
| Haplorhini | 1 | 2007 | 77 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2007 | 57 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2007 | 24 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 2555 | 0.020 |
Why?
|
| Carbachol | 1 | 2006 | 34 | 0.020 |
Why?
|
| Phospholipases A | 1 | 2006 | 46 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2009 | 615 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2007 | 165 | 0.020 |
Why?
|
| Intestine, Small | 1 | 2009 | 318 | 0.020 |
Why?
|
| Proteins | 1 | 2012 | 804 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 215 | 0.010 |
Why?
|
| Infant | 1 | 2013 | 3329 | 0.010 |
Why?
|
| Cell Division | 1 | 2007 | 689 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 639 | 0.010 |
Why?
|
| Transfection | 1 | 2007 | 883 | 0.010 |
Why?
|
| Computational Biology | 1 | 2008 | 614 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 2007 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 1331 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 2896 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 2002 | 161 | 0.010 |
Why?
|
| Strophanthidin | 1 | 2002 | 3 | 0.010 |
Why?
|
| Tetrodotoxin | 1 | 2002 | 49 | 0.010 |
Why?
|
| Sodium Channel Blockers | 1 | 2002 | 27 | 0.010 |
Why?
|
| Diastole | 1 | 2002 | 101 | 0.010 |
Why?
|
| Sodium Channels | 1 | 2002 | 131 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2002 | 340 | 0.010 |
Why?
|